Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
Article
Norden, Andrew D, Raizer, Jeffrey J, Abrey, Lauren E et al. (2010). Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
. JOURNAL OF NEURO-ONCOLOGY, 96(2), 211-217. 10.1007/s11060-009-9948-7
Norden, Andrew D, Raizer, Jeffrey J, Abrey, Lauren E et al. (2010). Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma
. JOURNAL OF NEURO-ONCOLOGY, 96(2), 211-217. 10.1007/s11060-009-9948-7
Norden, Andrew D; Raizer, Jeffrey J; Abrey, Lauren E; Lamborn, Kathleen R; Lassman, Andrew B; Chang, Susan M; Yung, WK Alfred; Gilbert, Mark R; Fine, Howard A; Mehta, Minesh; DeAngelis, Lisa M; Cloughesy, Timothy F; Robins, H Ian; Aldape, Kenneth; Dancey, Janet; Prados, Michael D; Lieberman, Frank; Wen, Patrick Y